Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogeneti
Keywords: Randomised phase II study; GST; Brostallicin; Doxorubicin; Soft tissue sarcoma;